Harvard Bioscience, Inc. (HBIO):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Harvard Bioscience, Inc. (HBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME58380D
◆発行会社(調査会社):GlobalData
◆発行日:2016年2月24日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Harvard Bioscience, Inc. (Harvard Bioscience) is a developer, manufacturer and marketer of scientific instruments, systems, and lab consumables for life science research, drug discovery, and clinical and environmental testing applications. The company’s product range is organized into five product families: fluidics that include syringe pumps and peristaltic pumps; lab equipment and supplies such as pipettes, glove, and tissue culture products among others for molecular biology labs; molecular analysis products that include spectrophotometers, microplate readers and amino acid analyzers; cell analysis products such as electroporation, electrofusion, and cell electrophysiology products; and physiology products that include instruments and accessories for tissue, organ, and animal based lab research. The company caters to research scientists, pharmaceutical and biotechnology companies. It has operations in North America and Europe. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience, Inc. (HBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Harvard Bioscience, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Harvard Bioscience Completes Acquisition Of Assets Of Coulbourn Instruments 10
Partnerships 11
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Equity Offering 12
Harvard Apparatus Regenerative Technology Raises USD3.6 Million in Public Offering of Shares 12
Harvard Apparatus Regenerative Technology Raises USD6.1 Million in Public Offering of Series B Convertible Preferred Stock 14
Acquisition 16
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience, Inc. – Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 24
Financial Announcements 24
Jul 30, 2015: Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million 24
Apr 30, 2015: Harvard Bioscience Reports First Quarter 2015 Financial Results 25
Feb 26, 2015: Harvard Bioscience Fourth Quarter 2014 Non-GAAP EPS Increases 100% Versus Fourth Quarter 2013 on Record Quarterly Revenues of $30.4 Million 27
Corporate Communications 29
Apr 30, 2015: Harvard Bioscience Appoints James Green to the Board of Directors and Announces Retirement of Robert Dishman From the Board 29
Feb 18, 2015: Harvard Bioscience Appoints Ryan Atienza to Vice President of Sales at Its Denville Scientific Subsidiary 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Harvard Bioscience, Inc., Medical Equipment, Key Facts, 2014 1
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Deals By Market, 2010 to YTD 2016 8
Harvard Bioscience, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9
Harvard Bioscience Completes Acquisition Of Assets Of Coulbourn Instruments 10
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Harvard Apparatus Regenerative Technology Raises USD3.6 Million in Public Offering of Shares 12
Harvard Apparatus Regenerative Technology Raises USD6.1 Million in Public Offering of Series B Convertible Preferred Stock 14
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience, Inc., Key Competitors 19
Harvard Bioscience, Inc., Key Employees 20
Harvard Bioscience, Inc., Subsidiaries 21

List of Figures
Harvard Bioscience, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Harvard Bioscience, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5
Harvard Bioscience, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6
Harvard Bioscience, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7
Harvard Bioscience, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

★海外企業調査レポート[Harvard Bioscience, Inc. (HBIO):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lingui Developments Berhad (LINGUI):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Lingui Developments Berhad" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • New China Life Insurance Company Ltd.:企業の戦略・SWOT・財務情報
    New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary New China Life Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Halma p.l.c. (HLMA):企業のM&A・提携動向(医療機器分野)
    Summary Halma p.l.c. (Halma) is a leading safety, health and sensor technology company. It focuses o the development, production and sale of life protection products. The company provides components and products used to enhance personal and public health. The product line of the company includes fir …
  • TricorBraun, Inc.:企業概要及びSWOT分析
    Summary Canadean's "TricorBraun, Inc.: Paper and Packaging - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company h …
  • Energy Transfer Partners, L.P.:企業の戦略・SWOT・財務分析
    SummaryEnergy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Telenor ASA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Telenor ASA Mergers and Acquisi …
  • Molinos Rio de la Plata S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Molinos Rio de la Plata S.A. Me …
  • Elos AB (ELOS B):企業概要、財務及び戦略的SWOT分析
    Summary Elos AB (Elos) is a medical technology company. It operates business in two business areas namely, Medical Technology and Metrology. The company’s Medical Technology division undertakes the development and production of medical technology products and components. It offers products such as d …
  • HFF, Inc.:企業の戦略・SWOT・財務分析
    SummaryHFF, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …
  • Fairstar Resources Limited (FAS):企業概要、財務及び戦略的SWOT分析
    Summary Fairstar Resources Limited (Fairstar Resources) is a mineral exploration company. The company acquires, explores and produces mineral resource such as gold, base metals, uranium and iron ores. Its projects include Steeple Hill Iron Project, Kurnalpi-Randalls, Mount Padbury, Spinifex Well, Mi …
  • CRYO-CELL International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CRYO-CELL International, Inc. M …
  • Honda Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryHonda Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • American Bio Medica Corporation (ABMC):企業概要、財務及び戦略的SWOT分析
    Summary American Bio Medica Corporation (ABMC) is a biotechnology company. The company develops, manufactures and markets immunoassay test kits, including point-of-collection tests for drugs of abuse in urine and oral fluids. Its products include Rapid TOX, Rapid One, Rapid TOX Cup II, Rapid Drug Sc …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Galp Energia, SGPS, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Galp Energia, SGPS, S.A. Merger …
  • Kunsul Chemical Industrial Co., Ltd. (000860):企業概要、財務及び戦略的SWOT分析
    Summary Kunsul Chemical Industrial Co., Ltd. (Kunsul) is a paints and coatings service provider. The company offers products and services to architectural, industrial, automotive, and heavy duty and marine sectors. It offers architectural products, professional products, diy products, and color book …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ennis, Inc. (EBF):企業の財務・戦略的SWOT分析
    Ennis, Inc. (EBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Travelzoo Inc.:企業の戦略・SWOT・財務分析
    SummaryTravelzoo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Rite Aid Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rite Aid Corp. Mergers and Acqu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆